1. Home
  2. LITB vs NXL Comparison

LITB vs NXL Comparison

Compare LITB & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITB
  • NXL
  • Stock Information
  • Founded
  • LITB 2007
  • NXL 2010
  • Country
  • LITB Singapore
  • NXL United States
  • Employees
  • LITB N/A
  • NXL N/A
  • Industry
  • LITB Catalog/Specialty Distribution
  • NXL Medical Specialities
  • Sector
  • LITB Consumer Discretionary
  • NXL Health Care
  • Exchange
  • LITB Nasdaq
  • NXL Nasdaq
  • Market Cap
  • LITB 32.7M
  • NXL 31.1M
  • IPO Year
  • LITB N/A
  • NXL 2022
  • Fundamental
  • Price
  • LITB $1.63
  • NXL $1.83
  • Analyst Decision
  • LITB
  • NXL Strong Buy
  • Analyst Count
  • LITB 0
  • NXL 1
  • Target Price
  • LITB N/A
  • NXL $5.00
  • AVG Volume (30 Days)
  • LITB 91.9K
  • NXL 106.1K
  • Earning Date
  • LITB 05-27-2025
  • NXL 05-09-2025
  • Dividend Yield
  • LITB N/A
  • NXL N/A
  • EPS Growth
  • LITB N/A
  • NXL N/A
  • EPS
  • LITB N/A
  • NXL N/A
  • Revenue
  • LITB $255,287,000.00
  • NXL $168,721.00
  • Revenue This Year
  • LITB N/A
  • NXL $79.59
  • Revenue Next Year
  • LITB N/A
  • NXL $334.65
  • P/E Ratio
  • LITB N/A
  • NXL N/A
  • Revenue Growth
  • LITB N/A
  • NXL 52.35
  • 52 Week Low
  • LITB $0.91
  • NXL $0.53
  • 52 Week High
  • LITB $6.00
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • LITB 47.45
  • NXL 45.35
  • Support Level
  • LITB $1.65
  • NXL $1.71
  • Resistance Level
  • LITB $2.12
  • NXL $1.89
  • Average True Range (ATR)
  • LITB 0.24
  • NXL 0.20
  • MACD
  • LITB -0.05
  • NXL 0.04
  • Stochastic Oscillator
  • LITB 13.00
  • NXL 41.46

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: